Vimarsana
Biggest News Aggregation in the World

Page 5 - Caroline Robert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caroline Robert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caroline Robert Today - Breaking & Trending Today

CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference - Vimarsana News

CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

Onxeo S.A.: Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts - Vimarsana News

Onxeo S.A.: Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts

This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the development of Onxeo's current and future programs Regulatory News: Onxeo

Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update - Vimarsana News

Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update News provided by Share this article Share this article MARLBOROUGH, Mass., May 13, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its financial results for the quarter ended March 31, 2021 and provided a business update. "This year has started out with great momentum across our pipeline, as we continue...

Gene-based blood test for melanoma spread evaluates treatment progress - Vimarsana News

Gene-based blood test for melanoma spread evaluates treatment progress

 E-Mail A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds. Led by NYU Grossman School of Medicine and Perlmutter Cancer Center researchers, the investigation looked at adults with undetectable levels of freely circulating tumor DNA (ctDNA) four weeks into drug treatment for metastatic melanoma tumors that cannot be removed surgically (unresectable). The study showed that these patients, all of whom had com...